149 related articles for article (PubMed ID: 3982560)
21. The relationship of cellular immunity to prognosis in acute leukemia.
Toki H; Takahashi Y; Nakanishi N; Naito T; Chen P; Takahashi I; Kitajima K
Acta Med Okayama; 1977 Feb; 31(1):51-8. PubMed ID: 140590
[TBL] [Abstract][Full Text] [Related]
22. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
[TBL] [Abstract][Full Text] [Related]
23. Assays of immunocompetence in the staging and prognosis of cancer.
Robinson JC
Surg Gynecol Obstet; 1981 Dec; 153(6):909-21. PubMed ID: 7029761
[TBL] [Abstract][Full Text] [Related]
24. Skin tests with autologous cholesteryl hemisuccinate-treated tumor cells, DNCB and PPD and their relationship to prognosis in malignant melanoma patients.
Munzarová M; Mechl Z; Kovarík J; Kolcová V
Neoplasma; 1988; 35(2):229-34. PubMed ID: 3374711
[TBL] [Abstract][Full Text] [Related]
25. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer.
Cunningham TJ; Daut D; Wolfgang PE; Mellyn M; Maciolek S; Sponzo RW; Horton J
Cancer; 1976 Apr; 37(4):1696-1700. PubMed ID: 1260685
[TBL] [Abstract][Full Text] [Related]
26. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
27. Proceedings: Relationship between the DNCB test and prognosis in cancer patients.
Dubois JB; Serrou B
Br J Surg; 1974 Apr; 61(4):326. PubMed ID: 4832661
[No Abstract] [Full Text] [Related]
28. [Study of the DNCB skin test in patients with solid neoplasms].
Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
[TBL] [Abstract][Full Text] [Related]
29. [DNCB-skin specimens for immunodiagnosis].
Sinn W
Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
[TBL] [Abstract][Full Text] [Related]
30. [DNCB test and immune competence. Analysis of patients with urologic neoplasms].
Klippel KF; Walz HP; Kreutz G; von Moltke T
MMW Munch Med Wochenschr; 1978 Aug; 120(31):1027-8. PubMed ID: 308155
[No Abstract] [Full Text] [Related]
31. [Non-specific immunologic reactivity among patients with primary multiple malignant neoplasms].
Tsukerman IM
Vopr Onkol; 1976; 22(7):11-4. PubMed ID: 997403
[TBL] [Abstract][Full Text] [Related]
32. The value of the DNCB test in bladder cancer. Pretreatment evaluation of immune function and 5-year follow-up of patients with urinary bladder cancer.
Flamm J; Sagaster P; Micksche M
Urol Int; 1984; 39(5):257-63. PubMed ID: 6506358
[TBL] [Abstract][Full Text] [Related]
33. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
Takanami I; Nakayama H; Ishihara T; Yanai N
Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
[TBL] [Abstract][Full Text] [Related]
34. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
Djawari D; Körner E; Haneke E
Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
[TBL] [Abstract][Full Text] [Related]
35. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
Lipenský R; Urban K
Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
[No Abstract] [Full Text] [Related]
36. Prognostic value of host immunocompetence in urologic cancer patients.
Catalona WJ; Smolev JK; Harty JI
J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
[TBL] [Abstract][Full Text] [Related]
37. [Sensitivity to tuberculin and dinitrochlorobenzene].
Pukhlik BM; Gandzeĭchuk TV; Lishchanovskaia GI; Stepanchuk NA
Probl Tuberk; 1982 Mar; (3):77-8. PubMed ID: 7088927
[No Abstract] [Full Text] [Related]
38. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
39. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of the DNCB skin test and CEA assay in the prognosis of malignant neoplasms].
Ciambellotti E; Moro G
Arch Sci Med (Torino); 1983; 140(3):267-72. PubMed ID: 6675584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
